Performance evaluation of the βLACTA™ Test for rapid detection of ceftazidime resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients

被引：1
|
作者：
Ract, Pauline [1 ,2 ]
Dahoumane, Redouane [4 ]
Gallah, Salah [3 ]
Morand, Philippe [5 ]
Podglajen, Isabelle [1 ,2 ]
Compain, Fabrics [1 ,2 ,6 ,7 ]
机构：
[1] Hop Europeen Georges Pompidou, AP HP, Serv Microbiol, Paris, France
[2] Univ Paris 05, Sorbonne Paris Cite, F-75006 Paris, France
[3] St Antoine Hosp, Dept Microbiol, Paris, France
[4] Hop Univ Est Parisiens, AP HP, Dept Bacteriol, Paris, France
[5] Cochin Hosp, Dept Microbiol, Paris, France
[6] Ctr Rech Cordeliers, INSERM UMRS 1138, Paris, France
[7] UPMC Univ Paris 06, Ctr Rech Cordeliers, Sorbonne Univ, Paris, France
来源：
JOURNAL OF MICROBIOLOGICAL METHODS | 2019年 / 158卷
关键词：
beta LACTA test; Ceftazidime; Cystic fibrosis; Pseudomonas; Rapid test; BETA-LACTA TEST; MECHANISMS; EMERGENCE;
D O I：
10.1016/j.mimet.2019.01.019
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
The chromogenic beta LACTA (TM) test was evaluated to detect ceftazidime resistance in P. aeruginosa isolates from patients with cystic fibrosis. Best results were obtained after one hour of incubation with low sensitivity (64.1%), high specificity (98.3%), and negative and positive predictive values of 80.3% and 96.2%, respectively.
引用
收藏
页码：21 / 24
页数：4
相关论文
共 50 条
  • [41] Efflux Pumps, OprD Porin, AmpC β-Lactamase, and Multiresistance in Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients
    Tomas, Maria
    Doumith, Michel
    Warner, Marina
    Turton, Jane F.
    Beceiro, Alejandro
    Bou, German
    Livermore, David M.
    Woodford, Neil
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (05) : 2219 - 2224
  • [42] Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patients
    Kos, Renate
    Brinkman, Paul
    Neerincx, Anne H.
    Paff, Tamara
    Gerritsen, Marije G.
    Lammers, Ariana
    Kraneveld, Aletta D.
    Heijerman, Harry G. M.
    Janssens, Hettie M.
    Davies, Jane C.
    Majoor, Christof J.
    Weersink, Els J.
    Sterk, Peter J.
    Haarman, Eric G.
    Bos, Lieuwe D.
    Maitland-van der Zee, Anke H.
    JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (01) : E28 - E34
  • [43] Phenotypic and genotypic characterization of Pseudomonas aeruginosa from cystic fibrosis patients
    I. Leone
    M. G. Chirillo
    T. Raso
    M. Zucca
    D. Savoia
    European Journal of Clinical Microbiology & Infectious Diseases, 2008, 27
  • [44] Antimicrobial Susceptibility of Pseudomonas aeruginosa Isolated from Cystic Fibrosis Patients in Northern Europe
    Mustafa, Muhammad-Hariri
    Chalhoub, Hussein
    Denis, Olivier
    Deplano, Ariane
    Vergison, Anne
    Rodriguez-Villalobos, Hector
    Tunney, Michael M.
    Elborn, J. Stuart
    Kahl, Barbara C.
    Traore, Hamidou
    Vanderbist, Francis
    Tulkens, Paul M.
    Van Bambeke, Francoise
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (11) : 6735 - 6741
  • [45] Genetic determinants of antimicrobial resistance in polymyxin B resistant Pseudomonas aeruginosa isolated from airways of patients with cystic fibrosis
    Simao, Felipe A.
    Almeida, Mila M.
    Rosa, Heloisa S.
    Marques, Elizabeth A.
    Leao, Robson S.
    BRAZILIAN JOURNAL OF MICROBIOLOGY, 2024, 55 (02) : 1415 - 1425
  • [46] Microbiological activity of ceftolozane/tazobactam, ceftazidime, meropenem, and piperacillin/tazobactam against Pseudomonas aeruginosa isolated from children with cystic fibrosis
    Kuti, Joseph L.
    Pettit, Rebecca S.
    Neu, Natalie
    Cies, Jeffrey J.
    Lapin, Craig
    Muhlebach, Marianne S.
    Novak, Kimberly J.
    Nguyen, Sean T.
    Saiman, Lisa
    Nicolau, David P.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2015, 83 (01) : 53 - 55
  • [47] Expression of Pseudomonas aeruginosa Antibiotic Resistance Genes Varies Greatly during Infections in Cystic Fibrosis Patients
    Martin, Lois W.
    Robson, Cynthia L.
    Watts, Annabelle M.
    Gray, Andrew R.
    Wainwright, Claire E.
    Bell, Scott C.
    Ramsay, Kay A.
    Kidd, Timothy J.
    Reid, David W.
    Brockway, Ben
    Lamont, Iain L.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (11)
  • [48] Antimicrobial Activity of Tobramycin Against Respiratory Cystic Fibrosis Pseudomonas aeruginosa Isolates from Bulgaria
    Strateva, T.
    Petrova, G.
    Mitov, I.
    JOURNAL OF CHEMOTHERAPY, 2010, 22 (06) : 378 - 383
  • [49] Antibiotic resistance evolution of Pseudomonas aeruginosa in cystic fibrosis patients (2010-2013)
    Lucca, Francesca
    Guarnieri, Margherita
    Ros, Mirco
    Muffato, Giovanna
    Rigoli, Roberto
    Da Dalt, Liviana
    CLINICAL RESPIRATORY JOURNAL, 2018, 12 (07) : 2189 - 2196
  • [50] Evaluation of in vitro activity of ceftolozane-tazobactam compared to other antimicrobial agents against Pseudomonas aeruginosa isolates from cystic fibrosis patients
    Gherardi, Giovanni
    Linardos, Giulia
    Pompilio, Arianna
    Fiscarelli, Ersilia
    Di Bonaventura, Giovanni
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2019, 94 (03) : 297 - 303
12345